Category: Hansen Medical Inc.
Hansen Medical launches its re-designed Artisan study, enrolling the initial 5 patients to evaluate robot-assisted catheter surgery for atrial fibrillation.
Hansen Medical (NSDQ:HNSN) enrolled the 1st 5 patients in a re-designed study to evaluate its robot-assisted atrial fibrillation treatment.
Hansen Medical misses Wall Street's expectations during the 2nd quarter, sending shares down today on The Street.
Hansen Medical (NSDQ:HNSN) shares slipped today after the medical device company missed expectations on Wall Street with wider losses and a more than 5% sales decline.
Hansen Medical inks an equity financing deal worth $93 million, sending share prices for the robotic surgery company up nearly 20% today.
Hansen Medical (NSDQ:HNSN) said it inked an equity financing deal for up to $93 million with a consortium of investors including Oracle Investment Management and private equity player Jack Schuler, a co-founder of Crabtree Partners.
Robotic surgery company Hansen Medical agrees to pay $4.25 million in cash and $4.25 million worth of its own stock to settle a shareholders' lawsuit filed over a 2009 restatement of its books.
Hansen Medical (NSDQ:HNSN) said it agreed to pay out $8.5 million in cash and stock to put to rest a shareholders' lawsuit filed over its 2009 restatement of revenues.
A survey of CEOs and venture capital players reveals the gap between what CEOs want from their backers and what VCs think CEOs want.
A survey of 158 CEOs and 216 venture capital firms revealed a large gap between the chief executives' wish list for potential backers and what VCs think the CEOs want.
Startup CEOs in the IT and life science industries want VCs who are "entrepreneur friendly" and "collaborative" without being too hands-on in their approach, according to a survey sponsored by the National Venture Capital Assn.
Hansen Medical and Philips Healthcare get E.U. regulatory certification acknowledging that their robot surgical platforms can work in harmony in the operating room.
ArjoHuntleigh lured a former Covidien executive as its new president of North American operations.
Illinois healthcare products maker ArjoHuntleigh hired Rick Lytle, a former Covidien (NYSE:COV) executive, as the new president of company operations in the U.S. and Canada.